Cleared Traditional

K142991 - LifeGlobal Global Total w/HSA, LifeGlobal Global Total for Fertilization w/HSA, LifeGlobal Global Total w/HEPES W/HSA

K142991 is an FDA 510(k) clearance for LifeGlobal Global Total w/HSA, manufactured by Life Global Group, LLC. The device is a Class 2 Obstetrics & Gynecology device with product code MQL cleared through the Traditional 510(k) pathway after a 124-day FDA review.

K142991 · Life Global Group, LLC · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2015
Decision
124d
Days
Class 2
Risk

K142991 is an FDA 510(k) clearance for the LifeGlobal Global Total w/HSA, LifeGlobal Global Total for Fertilization w/HS.... Classified as Media, Reproductive (product code MQL), Class II - Special Controls.

Submitted by Life Global Group, LLC (Gilford, US). The FDA issued a Cleared decision on February 17, 2015 after a review of 124 days - within the typical 510(k) review window.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6180 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K142991

510(k) Number K142991 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 16, 2014
Decision Date February 17, 2015
Days to Decision 124 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 161d · This submission: 124d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQL Device Classification - Class 2, Special Controls

Product Code MQL Media, Reproductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6180
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MQL Media, Reproductive

All 259
Devices cleared under the same product code (MQL) and FDA review panel - the closest regulatory comparables to K142991.
SYDNEY IVF EMBRYO BIOPSY MEDIUM
K152904 · William A. Cook Australia Pty. , Ltd. · Dec 2015
Sydney IVF PVP
K152440 · Willam A. Cook Australia Pty, Ltd. · Sep 2015
COOK Sydney IVF Blastocyst Vitrification Kit, COOK Sydney IVF Blastocyst Warming Kit
K143724 · William A. Cook Australia Pty. , Ltd. · Aug 2015
LifeGlobal Global HP
K143498 · Life Global Group, LLC · Jan 2015
G-TL
K133568 · Vitrolife, Inc. · Jul 2014
EMBRYOGEN
K140317 · Origio A/S · Jun 2014